European Regulators Approve Pembrolizumab (Keytruda) as First-line Treatment of Advanced Melanoma July 22, 2015December 14, 2022 Matthew Tontonoz
CRI Awards $29.3 Million to Fund Immunotherapies for All Kinds of Cancer August 6, 2015December 14, 2022 Alexandra Mulvey
What Patients Need to Know About Lung Cancer Immunotherapy August 14, 2015December 14, 2022 Michelle Liew
New Study Suggests a Common Heart Medication Could Help Cancer Patients Live Longer August 25, 2015December 14, 2022 Matthew Tontonoz
CRI’s James Allison to Receive Prestigious Lasker Award September 8, 2015December 14, 2022 Matthew Tontonoz